EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS182-08146 
Organism
Homo sapiens 
Tissue/cell
Spleen 
Coordinate
chr16:23519080-23520930 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EN2MA0642.1chr16:23520552-23520562CCCAATTAGC+6.02
NEUROD2MA0668.1chr16:23520415-23520425ACCATATGGC-6.02
RREB1MA0073.1chr16:23520341-23520361CCCCCAACCACCACCAAAAG+7.16
ZNF263MA0528.1chr16:23519813-23519834TCTTCTCCTTCCTCATTCTCC-6.38
ZNF263MA0528.1chr16:23519810-23519831CTCTCTTCTCCTTCCTCATTC-6.72
ZNF263MA0528.1chr16:23519819-23519840CCTTCCTCATTCTCCTCCATC-6.72
ZNF263MA0528.1chr16:23519816-23519837TCTCCTTCCTCATTCTCCTCC-7.39
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_10126chr16:23519164-23522612CD14
SE_11705chr16:23504583-23522799CD20
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr162351928623519482
Number: 1             
IDChromosomeStartEnd
GH16I023509chr162351940123519550
Enhancer Sequence
ACTGCACTCC AGCCTGGGCA ACAGAGCAAG ACTCCATCTC AAAAATAAAT AAATAAATAA 60
ATAAAAATAC ATTTAAAAAA AGCTAGAACT GGGGAGGCTG ATGTGGGAAA AATGCTTGAG 120
CCCAGGAGAG GGGTAAGCTG CAGTGAGCTG AGATCATGCC GCTGCACTCC AGCCTGGGTG 180
ACACAGTGAG ACTCTGTTTC AAAAAAAGCT GGAGTTGAAG AACTGTGTCC TTGGGCAGCC 240
TCAGTTCCAG GCACTCCTTT TATCTCCTCC ACCTGAGGCA GCTACTTTCT CTTACTCCGG 300
CTACTTTTTT TTTTTTTTTT TGAGACAGAA TCTCGCCTTG TCACCTAGGC TGGAGTGCAG 360
CGGTGCAATC TTGGCTCCAC CTCCACAACC TCTGCCCCAA GGGTTCAAGT GATCCTCCCA 420
CCTCGGCCTC CCAAGTAGCT GGAATTACAG GTGTGCGCCA CCACACATGG CTATTTTTTG 480
TATTTTAGTA GAGACGGGGT TTCACCATGT TGGCCAGGCT GGTCTTAAAC TCCTGGCCTC 540
AAAGGATTGG CCCACCTCAG CCTCCCAAAG TGCTGCGATT ACAGGCATGA ACAGCCTTTT 600
TTTCTAATTT TTGCAACTCC AGTCTAAGCC TTCTGTTCTC CATTGCCTCC TAAAACTACT 660
ACCTTCTGTC TCTACTGTTT AACTCAAGGA TGTCTCATTA AATAACTGGT TGGTTACCAA 720
ATTCAAAGTT CTCTCTTCTC CTTCCTCATT CTCCTCCATC TTTAAGGAGC AAAACTACGT 780
TACAACCACA TCCCTCCTTT GCTATCAGTG GGTGCCCCTG CAGGTCTCCC CCTGCCTGTT 840
TCTGCTCAGC CTTCAGTCTT CTCTTCCCAT CTGCCTCTTC AATGCTGGGG CTCCCCACGC 900
TCTCTTTCCA AACCTCTGCT CTTAATATAC GCAAGCTTCT CCCGCAAGCT CACTGCCAAT 960
GAACCAGACT CCCAAACCGT ACGTCCCACA CTTGCCCTCT CCAGTGCCAA CCAGCTGCCT 1020
AGAGGGCATC TCTTTTTTGA CTATGCCACA AGCACCTCAA ACTCCACATC TCAACCTTCT 1080
CTGCCTAAAC CAGCTCCTCC TCACAGGGGA GGCATCTGTA ACCCACCAGT TCCTCGAGCC 1140
TGAAACCCGC GATCTAGCCT AGATTTCTCC TTGTCCCCTG TCTGCATTCC AAGGCACCGA 1200
GGCTGCTGAC TACGCCTGCT CATTGCTTCT CCCTCTCCCC ACTGCCTTAG TCCTCCTGCG 1260
GCCCCCAACC ACCACCAAAA GAGCTTTTTA GCCGCTCTCC CTGCCTGAAG TCTCACCCTC 1320
TCCGCCCAAT TTAGCACCAT ATGGCTGCAA GTGACGCCTT TAACAGGCTT CCTTGATCAG 1380
ATTCTCCGGC TGAAAACTCC CAAACAGCAA CCCCGCCCTC GGATAAAACA TAAACTCCTT 1440
TCTGCAGCAC ACAAGGCTCT TGAAGATCTC GCCCCAATTA GCCGTGCAGC CCCTTTCCCG 1500
GATTCCTGAG CTTTAGGCTT GCACTCCAGC GGACTGACCT ACTTGTTCCC GGAGTGCTCC 1560
ACATTCTCTT GTCCCCAGCT TTTGCACACG CAGTTTCTTC TGCCTGGAAT GCGGTCGGCT 1620
GTGACGACCC CCAGGTAAAC CAACTCCTAC CACCACAGGT GAAACGAACG CCCTCCTCCT 1680
CCTCGCCAAT CCCGTTAGTA AGGTGATGTG ACTGCCGGCT TGTACCCACT AAAAAATGTT 1740
TTGGTGAGCA AGGACCCTGT GTTATGCATC TCAGTGTTCC TGGCACCTAG CAGAGCTGGG 1800
TACAAGGGGA ATATTCTTTA TCCCCTTTGA ACCTCAATCC CTCATTGGTA 1850